659 related articles for article (PubMed ID: 24158519)
1. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
[TBL] [Abstract][Full Text] [Related]
2. PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity.
Bojic LA; Telford DE; Fullerton MD; Ford RJ; Sutherland BG; Edwards JY; Sawyez CG; Gros R; Kemp BE; Steinberg GR; Huff MW
J Lipid Res; 2014 Jul; 55(7):1254-66. PubMed ID: 24864274
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor δ: a multifaceted metabolic player.
Bojic LA; Huff MW
Curr Opin Lipidol; 2013 Apr; 24(2):171-7. PubMed ID: 23481229
[TBL] [Abstract][Full Text] [Related]
5. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
[TBL] [Abstract][Full Text] [Related]
6. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
[TBL] [Abstract][Full Text] [Related]
7. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor δ inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein.
Bojic LA; Sawyez CG; Telford DE; Edwards JY; Hegele RA; Huff MW
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2919-28. PubMed ID: 23023367
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
[TBL] [Abstract][Full Text] [Related]
10. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
11. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
12. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator activated receptor-δ: the middle child vies for attention.
Rajagopal R; Semenkovich CF
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):5-7. PubMed ID: 24335675
[No Abstract] [Full Text] [Related]
14. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
Chen W; Wang LL; Liu HY; Long L; Li S
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):240-6. PubMed ID: 18684227
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
19. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
20. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.
Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH
Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
